BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
BioAtla, Inc. (BCAB) Reports In-Line Q3 EPS
November 13, 2025 4:09 PM ESTBioAtla, Inc. (NASDAQ: BCAB) reported Q3 EPS of ($0.27), in-line with the analyst estimate of ($0.27).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.
... More